Malignant melanoma treated with pembrolizumab during pregnancy: A case report and review of the literature

There have been very few reports on the use of immune checkpoint inhibitors for malignant tumors during pregnancy. Herein, the current study reports a case of a patient diagnosed with advanced malignant melanoma who was treated with pembrolizumab during pregnancy. A 40-year-old primigravida underwen...

Descripción completa

Detalles Bibliográficos
Autores principales: Anami, Yuki, Minami, Sawako, Kumegawa, Aya, Matsukawa, Hitomi, Nishioka, Kaho, Noguchi, Tomoko, Iwahashi, Naoyuki, Mizoguchi, Mika, Nanjo, Sakiko, Ota, Nami, Mabuchi, Yasushi, Yagi, Shigetaka, Yamamoto, Yuki, Ino, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506525/
https://www.ncbi.nlm.nih.gov/pubmed/34650809
http://dx.doi.org/10.3892/mco.2021.2404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506525/
https://www.ncbi.nlm.nih.gov/pubmed/34650809
http://dx.doi.org/10.3892/mco.2021.2404

Ejemplares similares